Fresenius plans to reduce stake in Fresenius Medical Care, selling shares and issuing bonds

From Nasdaq: 2025-03-03 19:41:11

Fresenius plans to reduce its stake in Fresenius Medical Care AG from 32.2% to no less than 25% plus one share. This involves selling about 10.5 million shares through an accelerated bookbuilding procedure and issuing bonds exchangeable into ordinary shares of Fresenius Medical Care. The final size of the instruments will be determined after the bookbuilding process. Proceeds will be used in line with #FutureFresenius strategy to strengthen the balance sheet, reduce leverage, and deliver long-term growth. Fresenius will remain the largest shareholder of FME and continue to actively support the management board.



Read more at Nasdaq: Fresenius Plans To Reduce Its Stake In Fresenius Medical Care